Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-07-22

Clinical Trial Update: A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated topical KD7040 for postherpetic neuralgia and has completed. The update does not include efficacy or safety results in the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical KD7040

Snippet

Sponsor: Kalypsys, Inc. | Conditions: Postherpetic Neuralgia, Shingles | Phase 2 | Status: COMPLETED